Cryo Cell International (CCEL) Long-Term Deferred Tax: 2010-2024
Historic Long-Term Deferred Tax for Cryo Cell International (CCEL) over the last 12 years, with FY2024 value amounting to $20.8 million.
- Cryo Cell International's Long-Term Deferred Tax rose 150.92% to $20.8 million in Q3 2025 from the same period last year, while for Aug 2025 it was $20.8 million, marking a year-over-year increase of 150.92%. This contributed to the annual value of $20.8 million for FY2024, which is 150.92% up from last year.
- Per Cryo Cell International's latest filing, its Long-Term Deferred Tax stood at $20.8 million for FY2024, which was up 150.92% from $20.5 million recorded in FY2023.
- In the past 5 years, Cryo Cell International's Long-Term Deferred Tax registered a high of $20.8 million during FY2024, and its lowest value of $10.4 million during FY2020.
- Its 5-year average for Long-Term Deferred Tax is $15.5 million, with a median of $13.7 million in 2022.
- Its Long-Term Deferred Tax has fluctuated over the past 5 years, first soared by 4912.06% in 2023, then soared by 150.92% in 2024.
- Cryo Cell International's Long-Term Deferred Tax (Annual) stood at $10.4 million in 2020, then rose by 15.88% to $12.0 million in 2021, then grew by 14.42% to $13.7 million in 2022, then surged by 49.12% to $20.5 million in 2023, then increased by 1.51% to $20.8 million in 2024.
- Its Long-Term Deferred Tax stands at $20.8 million for FY2024, versus $20.5 million for FY2023 and $13.7 million for FY2022.